Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration
Age-related macular degeneration (AMD) is a complex multifactorial degenerative disease that leads to irreversible blindness. AMD affects the macula, the central part of the retina responsible for sharp central vision. Retinal pigment epithelium (RPE) is the main cellular type affected in dry AMD. R...
Main Authors: | Monica Baiula, Alberto Caligiana, Andrea Bedini, Junwei Zhao, Federica Santino, Martina Cirillo, Luca Gentilucci, Daria Giacomini, Santi Spampinato |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.617836/full |
Similar Items
-
Novel Ligands Targeting α4β1 Integrin: Therapeutic Applications and Perspectives
by: Monica Baiula, et al.
Published: (2019-07-01) -
Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of α<sub>4</sub>β<sub>1</sub> Integrin
by: Monica Baiula, et al.
Published: (2023-05-01) -
Design of α/β-Hybrid Peptide Ligands of α4β1 Integrin Equipped with a Linkable Side Chain for Chemoselective Biofunctionalization of Microstructured Materials
by: Michele Anselmi, et al.
Published: (2021-11-01) -
Disintegrins: integrin selective ligands which activate integrin-coupled signaling and modulate leukocyte functions
by: Barja-Fidalgo C., et al.
Published: (2005-01-01) -
Editorial: Integrin Ligands and Their Bioconjugate Systems: Synthesis, Conformation, and Biological Activity
by: Rossella De Marco, et al.
Published: (2022-06-01)